Related Experiment Videos
Characterization of autoantigenic epitopes on platelet glycoprotein IIb/IIIa using random peptide libraries
R D Bowditch1, P Tani, K C Fong
1The Scripps Research Institute, La Jolla, CA 92037, USA.
Blood
|December 15, 1996
Summary
Researchers identified specific peptide sequences recognized by autoantibodies in immune thrombocytopenic purpura (ITP) patients targeting glycoprotein (GP) IIb/IIIa. This suggests a limited number of shared epitopes are recognized by ITP autoantibodies.
Area of Science:
- Immunology
- Hematology
- Molecular Biology
Background:
- Chronic immune thrombocytopenic purpura (ITP) is characterized by autoantibodies against the glycoprotein (GP) IIb/IIIa complex.
- Identifying specific epitopes targeted by these autoantibodies is crucial for understanding ITP pathogenesis.
Purpose of the Study:
- To identify linear peptide sequences recognized by autoantibodies from ITP patients.
- To investigate shared antigenic determinants on GP IIb/IIIa among ITP patients.
Main Methods:
- Utilized a filamentous phage display library to select for peptides binding to ITP patient autoantibodies.
- Characterized antibody binding using dose-dependent assays and inhibition studies with purified GP IIb/IIIa and synthetic peptides.
- Localized epitopes using sequential overlapping peptides from the GPIIIa cytoplasmic region.
Main Results:
- Identified specific hexapeptide sequences (e.g., REKAKW, PVVWKN) recognized by autoantibodies from ITP patients.
- Localized one epitope to the GPIIIa cytoplasmic sequence Arg-Ala-Arg-Ala-Lys-Trp (GPIIIa 734-739).
- Demonstrated that distinct autoantibodies from a single patient can recognize different epitopes.
- Found that the PVVWKN-encoding phage bound autoantibodies from two different ITP patients, indicating shared epitopes.
Conclusions:
- Phage display is effective in identifying autoantibody-reactive epitopes in ITP.
- ITP patients recognize a limited repertoire of shared antigenic determinants on GP IIb/IIIa.
- Further characterization of these shared epitopes may aid in developing targeted therapies for ITP.